| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net sales | 317,841 | - |
| Cost of product (excluding amortization) | 88,372 | - |
| Marketing expenses | 68,846 | - |
| Adjusted selling, general, and administrative | 77,695 | - |
| Depreciation and amortization | 40,276 | - |
| Interest expense | 33,791 | - |
| Interest income | 12,169 | - |
| Tax receivable agreement liability adjustment | 9,452 | - |
| Income tax (benefit) provision | -3,334 | - |
| Share-based compensation expense | 9,692 | - |
| Other segment items | 20,274 | - |
| Net income | 3,850 | -7,277 |
| Amortization of patent formulations | 7,280 | 4,576 |
| Amortization of other intangibles | 32,728 | 21,823 |
| Inventory write-off and disposal | 3,481 | 2,804 |
| Depreciation of fixed assets | 268 | 179 |
| Amortization of debt issuance costs | 3,602 | 3,314 |
| Deferred taxes | -4,739 | -1,444 |
| Tax receivable agreement liability adjustment | 9,452 | - |
| Share-based compensation expense | 9,692 | 6,381 |
| Acquisition-related costs in investing activities | 9,282 | - |
| Other | -877 | -641 |
| Accounts receivable, net | 34,691 | 17,696 |
| Inventory | 2,027 | 5,988 |
| Prepaid expenses and other current assets | 50,252 | 49,162 |
| Accounts payable | 13,246 | 14,653 |
| Accrued expenses and other current liabilities | 45,026 | 47,863 |
| Other assets and liabilities | 2,182 | 2,680 |
| Net cash provided by operating activities | 25,989 | 17,987 |
| Purchase of property and equipment | 222 | 151 |
| Acquisition-related costs | 10,587 | - |
| Purchase and development of software | 1,479 | 1,174 |
| Net cash used in investing activities | -12,288 | -1,325 |
| Proceeds from exercise of stock options | 527 | 527 |
| Payments for shares withheld and retired to cover tax withholding obligation for rsus | - | 0 |
| Payments made pursuant to tax receivable agreement | 12,129 | 12,129 |
| Principal payments of 2022 term loan facility | 301,688 | 301,688 |
| Net cash used in financing activities | -313,290 | -313,290 |
| Net (decrease) increase in cash and cash equivalents | -299,589 | -296,628 |
| Cash and cash equivalents at beginning of period | 585,967 | - |
| Cash and cash equivalents at end of period | 286,378 | - |
OLAPLEX HOLDINGS, INC. (OLPX)
OLAPLEX HOLDINGS, INC. (OLPX)